RxDoctor Payments Data

Jose Stolovitzky, MD

Otolaryngology · Atlanta, GANPI 1558368415

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (39.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Intersect ENT, Inc. at 34.9% of the total. Reporting peaked in 2024 at $30,832 and has fallen 90.0% since, to $3,087 in 2025. Among otolaryngology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,440in general payments, 2019–2025

Across 189 payments — averaging $430.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$28K
  • Medtronic$17K
  • GSK$13K
  • Aerin Medical Inc.$9K
  • Neurent Medical Limited$9K
  • Spirair, Inc.$3K
  • plus $2K from 12 others
$223,681in research payments, 2019–2025

Across 45 payments — averaging $4970.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intersect ENT, Inc.$100K
  • Aerin Medical Inc.$91K
  • AstraZeneca$24K
  • Medtronic$7K
  • Stryker$1K

What the payments were for

  • Consulting fees$25,85032%
  • Speaking & faculty fees$32,10039%
  • Travel & lodging$14,00117%
  • Food & beverage$9,48812%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$81,440 in reported general payments places this provider in the 95th percentile of 308 otolaryngology providers in Georgia.

See all otolaryngology providers in Georgia

Medicare billing

Part B allowed, 2024
$114,144
Medicare patients
124
Services billed
407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide93$1,921
Azelastine Hcl64$1,647
Mometasone Furoate14$1,165
Fluticasone Propionate118$1,141
Pantoprazole Sodium65$854
Doxycycline Hyclate53$518
Omeprazole35$403
Mupirocin42$299
Prednisone78$276
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$265

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →